Seminars

Launched in September of 2005, the ITMAT monthly seminar series enters its fourth year. Outstanding role models who pursue translational research, from outside of the Penn community, are invited to lecture in this series, which is being coordinated by Dan Rader, MD.

Speakers, who represent excellence in translational medicine and therapeutics are asked to spend a day as an ITMAT Visiting Professor. In addition to their scientific presentation, they are scheduled to meet with faculty and have an informal session with trainees focused on career development.

Seminar presentations are scheduled once a month, at 1:00 PM on a Friday and take place in room the Translation Research Center(TRC) Auditorium.

Click on Seminar Series Spring 2012 to view the schedule of upcoming lectures.

Institute for Translational Medicine and Therapeutics Seminars

ITMAT Scholars Seminar

  • January 20, 2012

    Nuclear Receptor Control of Lipid Metabolism
    Peter Tontonoz, M.D., Ph.D
    University oc California, Los Angeles

  • February 17, 2012

    Adipocyte-Derived Factors: Physiological Role and Clinical Relevance
    Philipp Scherer, Ph.D.
    University of Texas Southwestern Medical Center

  • March 23, 2012

    The Patient  is Always Right: Novel Mechanisms for Regulating Nitric Oxide Production
    Brendan Lee, M.D., Ph.D.
    Bayor College of Medicine

  • April 20, 2012

    The INK4A (CDKN2A) locus: regulating cellular self-renewal
    Charles J. Sherr., M.D., Ph.D
    St. Jude Children's Research Hospital

  • May 11, 2012

    Enzyme Replacement and Enhancement Therapies for Fabry Disease
    Robert J. Desnick, M.D.,Ph.D.
    Mount Sinai School of Medicine

  • June 8, 2012

    TBA
    William R. Bishai, M.D., Ph.D,
    Johns Hopkins Medicine

 

Targeted Therapeutics Seminar Series

    Seminar presentations are scheduled once a month, at 12:00 PM on a Wednesday and take place in room the Translation Research Center(TRC) Auditorium.

    Click on Seminar Series 2011-2012 to view the schedule of upcoming lectures

  • January 11, 2012

    Ultra-pH Sensitive (UPS) Nanomedicine: Amplifying Tumor Microenvironment Signals for Cancer-Specific Imaging
    Jinming Gao, Ph.D
    University of Texas Southwestern Medical Center

  • February 15, 2012

    The Role of Nanomedicine for the Assesment and Treatment of Athersclerotic Plaque
    Zahi A. Fayad, Ph.D
    Mount Sinai School of Medicine

  • March 7, 2012

    Nanopharmaceuticals: Versatile Drug Delivery Platform for Small Molecules and Biomolecules
    Sonke Svenson, Ph.D
    Director, Research, Cerulean Pharma, Inc

  • April 11, 2012

    Development of bioreducible polycationic (pro) drugs for nucleic acid delivery
    David Oupicky, Ph.D
    Wayne State University

  • May 16, 2012

    Tumor-targeting of nanoparticles self-assembled from recombinant viral protien
    Lali K. Medina-Kauwe, Ph.D
    University of California, Los Angeles, Geffen School of Medicine

» Top